XML 44 R26.htm IDEA: XBRL DOCUMENT v3.5.0.2
Goodwill and Intangible Assets (Tables)
 9 Months Ended
Sep. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]  
Summary of intangible assets by major asset class
The following sets forth the goodwill and intangible assets by major asset class:
 
 
 
 
September 30, 2016
 
December 31, 2015
 
Useful
Life
(Yrs)
Gross
 
Accumulated
Amortization
 
Net Book
Value
 
Gross
 
Accumulated
Amortization
 
Net Book
Value
Non-Amortizing:
 
 
 
 
 
 
 
 
 
 
 
 
 
Goodwill(a)
 
 
$
10,513,371

 
$
—

 
$
10,513,371

 
$
10,113,371

 
$
—

 
$
10,113,371

Amortizing:
 
 
 
 
 
 
 
 
 
 
 
 
 
Patents
8 – 17
 
5,802,528

 
(5,599,335
)
 
203,193

 
5,802,528

 
(5,516,122
)
 
286,406

Licenses
8 – 17
 
1,323,761

 
(1,154,674
)
 
169,087

 
1,323,761

 
(1,133,113
)
 
190,648

CELLECTRA®(b)
5 – 11
 
8,106,270

 
(6,718,257
)
 
1,388,013

 
8,106,270

 
(6,397,947
)
 
1,708,323

GHRH(b)
11
 
335,314

 
(232,344
)
 
102,970

 
335,314

 
(208,581
)
 
126,733

Bioject (c)
2 – 15
 
5,100,000

 
(351,389
)
 
4,748,611

 
—

—

—

 
—

Other(d)
18
 
4,050,000

 
(2,625,000
)
 
1,425,000

 
4,050,000

 
(2,456,250
)
 
1,593,750

Total intangible assets
 
 
24,717,873

 
(16,680,999
)
 
8,036,874

 
19,617,873

 
(15,712,013
)
 
3,905,860

Total goodwill and intangible assets
 
 
$
35,231,244

 
$
(16,680,999
)
 
$
18,550,245

 
$
29,731,244

 
$
(15,712,013
)
 
$
14,019,231


(a)
Goodwill was recorded from the Inovio AS acquisition in January 2005, the acquisition of VGX in June 2009 and the acquisition of Bioject in April 2016 for $3.9 million, $6.2 million and $400,000, respectively.
(b)
CELLECTRA® and GHRH are developed technologies which were recorded from the acquisition of VGX.
(c)
Bioject intangible assets represent the fair value of developed technology and intellectual property which were recorded from the acquisition of Bioject.
(d)
Other intangible assets represent the fair value of acquired intellectual property from the Inovio AS acquisition.